Lutein Absorption in Healthy Adults

July 2, 2013 updated by: Abbott Nutrition
This study will evaluate the absorption of lutein when consumed in different oil blends.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Addison, Illinois, United States, 60101
        • Biofortis Clinical Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Subjects will be eligible for the study if they meet all of the following inclusion criteria:

  • BMI ≥ 18 and ≤ 25 kg/m2
  • Between 18 and 45 years of age, inclusive
  • Male or a non-pregnant, non-lactating female, nulliparous or at least 6 weeks postpartum prior to screening visit. A urine pregnancy test is required for all female subjects unless she is not of childbearing potential. If female is of childbearing potential, is practicing one of the following methods of birth control (and will continue through the duration of the study):

    • Condoms, sponge, diaphragm or intrauterine device;
    • Oral or parenteral contraceptives for 3 months prior to screening visit;
    • Vasectomized partner;
    • Total abstinence from sexual intercourse.
  • If on a chronic medication, subject has been on constant dosage for at least two months prior to screening visit

Exclusion Criteria:

Subjects will be excluded from the study if they meet any of the following criteria:

  • Current smoker
  • Current chronic disease, including malabsorption or gastrointestinal disorders; hyperlipidemia; anemia; hemophilia; excessive bleeding; cystic fibrosis; kidney disease requiring dialysis; diabetes; active malignancy; wasting condition
  • Current chronic contagious, infectious disease, such as active tuberculosis, Hepatitis B or C,or HIV
  • Vegetarian, or has very selective food habits/dieting
  • Average intake of alcoholic beverages greater than 2 drinks per day
  • Medication or dietary supplement use to lower plasma lipids or affect lipid absorption or transport, including antibiotics
  • Supplement use that contains carotenoids (multi-vitamin as an example)
  • Known allergy or intolerance to any ingredient found in the study products

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control capsule
2 capsules
delivered in capsule form
Experimental: Experimental capsule
2 capsules
delivered in capsule form

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plasma lutein
Time Frame: baseline and 336 hours
adjusted area under the curve at specified postprandial timepoint
baseline and 336 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plasma carotenoids
Time Frame: 2, 4, 6, 8, 12, 24, 48, and 336 hours
mean concentrations at specified postprandial timepoints
2, 4, 6, 8, 12, 24, 48, and 336 hours
Plasma lipid concentrations
Time Frame: baseline and 48 hours
averaged concentrations at specified postprandial timepoints
baseline and 48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Jennifer Williams, Abbott Nutrition

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2012

Primary Completion (Actual)

March 1, 2013

Study Completion (Actual)

March 1, 2013

Study Registration Dates

First Submitted

November 16, 2012

First Submitted That Met QC Criteria

November 16, 2012

First Posted (Estimate)

November 21, 2012

Study Record Updates

Last Update Posted (Estimate)

July 4, 2013

Last Update Submitted That Met QC Criteria

July 2, 2013

Last Verified

July 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • BL14

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Subjects

Clinical Trials on Study product containing lutein

3
Subscribe